Advances in Prevention and Surveillance of Cutaneous Malignancies
- PMID: 31712100
- PMCID: PMC7709483
- DOI: 10.1016/j.amjmed.2019.10.008
Advances in Prevention and Surveillance of Cutaneous Malignancies
Abstract
Skin cancer affects 1 in 5 Americans, resulting in significant morbidity and mortality. Treatment costs and rates of skin cancer and melanoma continue to rise, making preventative measures increasingly important. However, there is conflicting evidence about efficacy of primary and secondary prevention strategies in decreasing incidence and improving early diagnosis. The US Preventative Services Task Force 2016 guidelines did not endorse routine skin cancer screening because of "insufficient evidence." Yet, countries like Australia have shown the feasibility and cost-effectiveness of primary sun safety interventions and secondary prevention measures such as routine skin cancer surveillance. Additional emerging evidence shows that regular skin cancer screening in high-risk populations improves early detection and decreases melanoma mortality. New technology may enhance prevention, promote accurate diagnoses, and improve management of melanoma and nonmelanoma skin cancers. Here, we place rising rates of melanoma within historical context, review costs, efficacy, and evidence for primary and secondary skin cancer prevention and examine the evolving role of novel technologies in the field.
Keywords: Melanoma; Primary prevention; Secondary prevention; Sun safety; Sunscreen.
Copyright © 2019 Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures

Similar articles
-
Melanoma screening: Informing public health policy with quantitative modelling.PLoS One. 2017 Sep 25;12(9):e0182349. doi: 10.1371/journal.pone.0182349. eCollection 2017. PLoS One. 2017. PMID: 28945758 Free PMC article.
-
Public education and cancer of the skin. What do people need to know about melanoma and nonmelanoma skin cancer?Cancer. 1995 Jan 15;75(2 Suppl):613-36. doi: 10.1002/1097-0142(19950115)75:2+<613::aid-cncr2820751403>3.0.co;2-g. Cancer. 1995. PMID: 7804987 Review.
-
Skin cancer in the military: A systematic review of melanoma and nonmelanoma skin cancer incidence, prevention, and screening among active duty and veteran personnel.J Am Acad Dermatol. 2018 Jun;78(6):1185-1192. doi: 10.1016/j.jaad.2017.11.062. Epub 2017 Dec 30. J Am Acad Dermatol. 2018. PMID: 29291955 Free PMC article.
-
Improving the prevention and diagnosis of melanoma on a national scale: A comparative study of performance in the United Kingdom and Australia.J Public Health Policy. 2020 Mar;41(1):28-38. doi: 10.1057/s41271-019-00187-0. J Public Health Policy. 2020. PMID: 31477796
-
[Epidemiology and prevention of melanoma].Rev Prat. 2004 Jun 15;54(11):1181-6. Rev Prat. 2004. PMID: 15496024 Review. French.
Cited by
-
A Narrative Review of Current Knowledge on Cutaneous Melanoma.Clin Pract. 2024 Jan 26;14(1):214-241. doi: 10.3390/clinpract14010018. Clin Pract. 2024. PMID: 38391404 Free PMC article. Review.
-
Addressing the unmet needs of patients with BRAF-mutated melanoma in Latin America: Expert perspective.Front Oncol. 2023 Mar 14;13:1032300. doi: 10.3389/fonc.2023.1032300. eCollection 2023. Front Oncol. 2023. PMID: 36998456 Free PMC article. Review.
-
Harnessing the Potential of Non-Apoptotic Cell Death Processes in the Treatment of Drug-Resistant Melanoma.Int J Mol Sci. 2023 Jun 20;24(12):10376. doi: 10.3390/ijms241210376. Int J Mol Sci. 2023. PMID: 37373523 Free PMC article. Review.
-
The Impact of Hyaluronan on Tumor Progression in Cutaneous Melanoma.Front Oncol. 2022 Jan 21;11:811434. doi: 10.3389/fonc.2021.811434. eCollection 2021. Front Oncol. 2022. PMID: 35127523 Free PMC article. Review.
-
Biomarkers in Cutaneous Keratinocyte Carcinomas.Dermatol Ther (Heidelb). 2024 Aug;14(8):2039-2058. doi: 10.1007/s13555-024-01233-w. Epub 2024 Jul 20. Dermatol Ther (Heidelb). 2024. PMID: 39030446 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical